CSS
PMVP icon

Cubist Systematic Strategies’s PMV Pharmaceuticals PMVP Stock Holding History

Cubist Systematic Strategies’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$61.4K Buy
+43,869
New +$60.7K ﹤0.01% 2830
2025
Q1 		– Sell
-2,595
Closed -$3.92K – 3380
2024
Q4 		$3.92K Sell
2,595
-6,053
-70% -$9.59K ﹤0.01% 2883
2024
Q3 		$12.9K Sell
8,648
-61,219
-88% -$94.6K ﹤0.01% 2840
2024
Q2 		$113K Buy
69,867
+59,452
+571% +$107K ﹤0.01% 2606
2024
Q1 		$17.7K Sell
10,415
-3,803
-27% -$7.1K ﹤0.01% 3482
2023
Q4 		$44.1K Buy
+14,218
New +$37.6K ﹤0.01% 3282
2023
Q2 		– Sell
-84,517
Closed -$403K – 4129
2023
Q1 		$403K Buy
84,517
+4,388
+5% +$30.9K ﹤0.01% 2807
2022
Q4 		$697K Sell
80,129
-97,949
-55% -$1.04M ﹤0.01% 2766
2022
Q3 		$2.12M Buy
178,078
+131,254
+280% +$1.9M 0.01% 1960
2022
Q2 		$667K Buy
+46,824
New +$681K ﹤0.01% 2818
2022
Q1 		– Sell
-66,743
Closed -$1.54M – 3728
2021
Q4 		$1.54M Buy
66,743
+26,992
+68% +$652K 0.01% 1597
2021
Q3 		$1.19M Buy
39,751
+28,152
+243% +$899K 0.01% 1388
2021
Q2 		$396K Buy
+11,599
New +$387K ﹤0.01% 2161

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cubist Systematic Strategies's PMVP Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in PMV Pharmaceuticals (PMVP) in Q3 2025: 43,869 shares worth $61.4K. The stake represents ﹤0.01% of the portfolio and ranks #2830 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in PMVP as recently as Q4 2024.

Cubist Systematic Strategies first reported a position in PMVP in Q2 2021 and has held it in 13 quarters since. The position peaked at $2.12M in Q3 2022. 64 funds tracked by Wall St. Rank hold PMVP as of Q3 2025.

  • Cubist Systematic Strategies held 43,869 shares of PMV Pharmaceuticals worth $61.4K as of Q3 2025.
  • PMV Pharmaceuticals was a new Cubist Systematic Strategies position in Q3 2025.
  • PMV Pharmaceuticals made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2830 holding.
  • Cubist Systematic Strategies first reported a position in PMV Pharmaceuticals in Q2 2021 and has held it in 13 quarters since.
  • Cubist Systematic Strategies's PMV Pharmaceuticals position peaked at $2.12M in Q3 2022.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.